Skip to main content

Susan Quaggin

Equibles does not estimate personal net worth.

Get an email with a short summary when AbbVie Inc. publishes a filing, an earnings call transcript or a press release.

Get ABBV alerts

About Susan Quaggin

Susan Quaggin is recorded as Board Member at AbbVie Inc. (ABBV) since October 11, 2023. AbbVie Inc. reported in an 8-K filed October 12, 2023 that Susan Quaggin was appointed Class III director, effective October 11, 2023. AbbVie Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at AbbVie Inc. includes Robert A. Michael (CEO, Chairman, CFO, COO and Board Member), Richard A. Gonzalez (Chairman), Scott T. Reents (CFO) and 3 others.

“On October 11, 2023, AbbVie Inc. ("AbbVie") expanded the size of its Board of Directors (the "Board") from eleven directors to thirteen directors and appointed Jennifer Davis as a Class II director and Susan Quaggin as a Class III director.”
AbbVie Inc. Form 8-K, filed October 12, 2023 · Read the filing

Affiliation history

Company network

Current role

Drug Manufacturers - General · Healthcare

Board Member

2023-10-11–present

Leadership on record at AbbVie Inc.

Recent activity